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Background: The impact of body mass index (BMI) on the prognosis of patients with colorectal cancer remains
largely unknown, particularly in Asian populations. Therefore, the aim of this study was to examine the influence of
BMI on clinicopathological characteristics and mortality of Chinese colorectal cancer patients.
Methods: The study cohort consisted of 525 patients who were diagnosed with colorectal cancer and underwent
radical surgery at the second hospital of Harbin Medical University between June 2004 and August 2011.
Study participants were divided into two BMI categories: normal weight (BMI <23 kg/m2) and overweight
(BMI ≥23 kg/m2).
Results: Of 525 patients, 208 patients (39.6%) were included in the normal-weight group and 317 patients were
included in the overweight group. During the mean follow-up period of 48.8 months, 89 patients had disease
recurrence and 131 deaths occurred. High BMI was significantly correlated with younger age, presence of diabetes,
alcohol consumption, distal colon tumors, amount of lymph node harvested and pathological stage. No statistically
significant correlation was found between high BMI and progression-free survival (PFS) or overall survival (OS) when
the total group of patients was considered (P = 0.077 and P = 0.701, respectively). Cigarette-smoking patients had
significantly shorter OS than patients who had never smoked (hazard ratio = 1.613, 95% confidence interval = 1.133
to 2.296; P = 0.008), and this difference in OS remained significant in multivariate analysis. Cigarette-smoking
patients did not have significantly different PFS compared with patients who had never smoked.
Conclusion: There was no significant correlation between obesity and outcomes of patients with colorectal cancer.
In addition, our findings support the claims that cigarette smoking may be partially responsible for the divergent
mortality of patients with colorectal cancer.
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The prevalence of obesity and excessive weight has dramat-
ically increased over previous decades, and a further in-
crease is expected in the future [1]. A mounting body of
epidemiological evidence indicates that westernized lifestyle
and resulting overweight or obesity are responsible for the
development of colorectal cancer [2-6]. The observation is
possibly a result of increased insulin resistance and higher* Correspondence: liubingrong@medmail.com.cn
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reproduction in any medium, provided the orconcentrations of insulin and insulin-like growth factor I,
which promote cell proliferation and inhibit apoptosis
[7-10]. Several molecular mechanisms have been proposed
to explain the relation between body mass index (BMI) and
colorectal cancer risk, including CTNNB1 gene and tumor
microsatellite instability status [11,12].
The impact of obesity on the prognosis of patients
with colorectal cancer is complicated, and a limited
number of studies indicate somewhat different effects
[13-17]. Moreover, the association of BMI with morbid-
ity of colorectal cancer has not been well-characterized
in Asian populations [14,18]. To this end, we examined
the association between BMI-defined obesity and theThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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for colorectal cancer in a Chinese population.Methods
Patients
We retrospectively studied a total of 525 patients diagnosed
with colorectal cancer who underwent radical surgery at
the second hospital of Harbin Medical University between
June 2004 and August 2011. Patients with any history of
cancer and those who had familial adenomatous polyposis
syndrome or hereditary nonpolyposis colorectal cancer
were excluded from our study. Written consent was
obtained from each patient, and the local ethics committee
of second affiliated hospital of Harbin Medical University
approved this study.Table 1 Baseline characteristics of patients included in the st
Characteristics All cases Nor
(BMI
No. of patients (%) 525 (100%) 2
Mean age (±SD), years 63.2 ± 11.7 6
Males, n (%) 310 (59%) 11
Diabetes, n (%) 86 (16.4%) 2
Alcohol consumption, n (%) 129 (24.6%) 4
Smoking, n (%) 160 (30.5%) 6
CEA ≥5 ng/ml, n (%) 215 (41.0%) 8
Site, n (%)
Rectum 287 (54.7%) 9
Distal colon 116 (22.1%) 4
Proximal colon 122 (23.2%) 6
Tumor size, n (%)
<5 cm 332 (63.2%) 1
≥5 cm 193 (36.8%) 8
Pathological type, n (%)
Adenocarcinoma 462 (88.0%) 1
others 63 (12.0%) 3
Differentiation, n (%)
Well/moderate 436 (83.0%) 1
Poor 89 (17.0%) 3
Mean nodes analyzed (±SD) 13.6 ± 8.2 1
Lymph node-positive, N (%) 225 (42.9%) 7
Stage, n (%)
I 83 (15.8%) 2
II 192 (36.6%) 9
III 165 (31.4%) 5
IV 85 (16.2%) 3
aBMI, body mass index; CEA, carcinoembryonic antigen.Data collection
Data collection included family history, smoking history,
history of alcohol consumption, history of diabetes mellitus,
surgical outcomes, clinicopathological factors, chemother-
apy administered and survival. Body weight was measured
on the admission day. BMI was calculated as weight in kilo-
grams divided by height in meters squared. According to
the World Health Organization (WHO) classification for
Asian populations, the patients were categorized as under-
weight (BMI <18.5), normal weight (18.5 ≤ BMI < 23.0),
overweight (23.0 ≤ BMI < 27.5) or obese (BMI ≥27.5) [19].
Because the numbers of patients in the underweight group
and the obese group were small, we divided all patients into
two groups based on a BMI above or below 23.0. Patients
were categorized according to whether they had ever or
never smoked or had ever or never consumed alcohol.udy according to body mass indexa
mal weight Overweight P
<23 kg/m2) (BMI ≥23 kg/m2)
08 (39.6%) 317 (60.4%)
4.5 ± 12.4 62.4 ± 11.1 0.003
3 (36.5.0%) 197 (63.5%) 0.075
5 (12.0%) 61 (19.2%) 0.029
1 (19.7%) 88 (27.8%) 0.036
1 (29.3%) 99 (31.2%) 0.643
7 (41.8%) 128 (40.4%) 0.741
3.6 × 10–4
8 (47.1%) 189 (59.6%)
3 (20.7%) 73 (23.0%)
7 (32.2%) 55 (17.4%)
0.513
28 (62.5%) 204 (64.4%)
0 (38.5%) 113 (35.6%)
0.166
78 (85.6%) 284 (89.6%)
0 (14.4%) 33 (10.4%)
0.764
74 (83.7%) 262 (82.6%)
4 (16.3%) 55 (17.4%)
4.8 ± 9.0 12.9 ± 7.6 0.007
9 (38.0%) 146 (46.1%) 0.067
0.008
6 (12.5%) 57 (18.0%)
0 (43.3%) 102 (32.2%)
3 (25.5%) 112 (35.3%)
9 (18.8%) 46 (14.5%)
Figure 1 Relationship between body mass index and clinical outcomes of colorectal cancer patients. A, Kaplan-Meier survival curve
demonstrating high BMI was not significantly related to progression-free survival; B, Kaplan-Meier survival curve demonstrating high BMI was not
significantly related to overall survival.
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cal resection with adjuvant chemotherapy for node-
positive patients and node-negative patients with adverse
pathological features. Most rectal cancer patients with
T3 or T4 tumors were offered neoadjuvant therapy in-
cluding a regimen of 5-fluorouracil and radiation ther-
apy. After surgery, evaluation of fecal occult blood,
carcinoembryonic antigen (CEA) measurement, chest X-
ray, computed tomography (CT) and colonoscopy were
carried out regularly. Recurrence was defined as the earl-
ier date follow-up event, such as elevated CEA or abnor-
mal findings on the CT scan or colonoscopy. The
progression-free survival (PFS) and overall survival (OS)
were defined from the date of diagnosis to the date of
recurrence and death or the latest follow-up,
respectively.
Statistical analysis
Statistical analysis was performed using SPSS version
17.0 software (SPSS, Chicago, IL, USA). All P values are
two-sided. Any difference in clinical features was
assessed using a χ2 test, Mann–Whitney U test and ana-
lysis of variance for continuous variables. Survival was
analyzed using the Kaplan-Meier method and compared
using a logrank test.
Results
Baseline characteristics
Of 525 eligible patients, 28 patients (5.3%) were under-
weight (<18.5 kg/m2), 180 patients (34.3%) were normal
weight (18.5 ≤ BMI < 23.0), 245 patients (46.7%) wereoverweight (23.0 ≤ BMI < 27.5) and 72 patients were
obese (BMI ≥27.5). Two hundred eight patients (39.6%)
were included in the normal-weight group (BMI <23.0),
and 317 patients (60.4%) were included in the over-
weight group (BMI ≥23.0). Baseline characteristics and
clinicopathological features are provided in Table 1.
Higher BMI showed a significant correlation with
younger age, presence of diabetes, alcohol consumption,
distal site of colon tumor, less lymph node harvested
and lower stage (Table 1). There were no significant dif-
ferences between the two groups with regard to smok-
ing, serum CEA, tumor size, pathological type and
differentiation grade (Table 1).
Body mass index, smoking and survival
In total, 89 patients (20.2%) without distant metastasis at
diagnosis had disease recurrence after a median follow-up
of 48.8 months (range = 5 to 97 months). The median PFS
was 44 months (range = 3 to 97 months), and five-year OS
was 75.0% for all stages in the whole series. During follow-
up, a total of 131 patient deaths (25%) were encountered,
with an even distribution between the BMI strata (26.0% vs.
24.3%; P = 0.665). No statistically significant correlation
was found between high BMI and PFS or OS when the
total group of patients was considered (P = 0.077 and
P = 0.701, respectively) (Figure 1A and B, Table 2). The PFS
and OS were also similar in the two BMI categories
(P = 0.088 and P = 0.424, respectively), even in the 440-
patient subgroup analysis, which included the patients
without primary metastasis at the time of surgery. Even in
the male and female subcohorts, PFS and OS were similar
Table 2 Mean progression-free survival and overall survival for various characteristics based on Kaplan-Meier analysisa
Variables Mean PFS P Mean OS P
(95% CI) (95% CI)
BMI 0.077 0.701
<23 kg/m2 79.4 (74.6 to 84.2) 71.9 (66.9 to 76.9)
≥23 kg/m2 77.2 (72.9 to 81.4) 75.0 (70.8 to 79.3)
Mean age 0.628 0.727
<60 years 78.9 (74.0 to 83.8) 74.6 (69.6 to 79.6)
≥60 years 78.3 (74.0 to 82.6) 74.0 (69.7 to 78.3)
Gender 0.112 0.043
Male 75.3 (71.1 to 79.6) 71.1 (67.0 to 75.1)
Female 81.3 (76.9 to 86.8) 77.3 (72.0 to 82.6)
Diabetes 0.158 0.884
Yes 70.2 (61.9 to 78.5) 69.2 (60.5 to 77.8)
No 80.3 (76.8 to 83.8) 74.9 (71.3 to 78.4)
Alcohol 0.291 0.088
Yes 75.1 (68.3 to 81.9) 69.2 (62.6 to 75.8)
No 80.1 (76.4 to 83.7) 76.2 (72.4 to 80.0)
Smoking 0.222 0.007
Yes 74.7 (68.5 to 80.9) 67.9 (62.0 to 73.8)
No 80.3 (76.5 to 84.1) 76.9 (72.9 to 80.8)
Site 0.289 0.788
Colon 78.4 (74.0 to 82.8) 73.2 (68.8 to 77.7)
Rectum 77.5 (73.0 to 82.1) 74.0 (69.5 to 78.5)
Tumor size 0.903 0.015
<5 cm 79.8 (75.8 to 83.8) 78.1 (74.0 to 82.3)
≥5 cm 77.4 (72.0 to 82.9) 69.2 (64.0 to 74.4)
Pathological type 0.291 2.5 × 10–4
Adenocarcinoma 79.9 (76.5 to 83.3) 76.7 (73.2 to 80.3)
Others 71.7 (61.5 to 82.0) 59.2 (50.2 to 68.3)
Differentiation 0.112 4.0 × 10–5
Grade 3/4 80.4 (77.0 to 83.9) 78.0 (74.6 to 81.4)
Grade 1/2 67.3 (59.1 to 75.4) 57.1 (49.7 to 64.5)
Lymph nodes harvested 0.910 0.575
≥12 79.3 (74.4 to 84.2) 73.4 (68.4 to 78.5)
<12 76.3 (72.2 to 80.3) 73.0 (69.0 to 77.1)
Lymph nodes positive 1.5 × 10–7 2.0 × 10–13
Positive 67.8 (61.9 to 73.8) 60.9 (55.6 to 66.3)
Negative 85.4 (81.8 to 89.0) 84.6 (80.9 to 88.3)
aBMI, body mass index; CI, confidence interval; OS, overall survival; PFS, progression-free survival.
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men, respectively; P = 0.110 and P = 0.933 for women,
respectively).
The BMI and cigarette smoking interaction was not sig-
nificant (P = 0.322), indicating that smoking status was not
significantly related to BMI. In both sexes, univariate
analysis revealed that cigarette-smoking patients hadsignificantly shorter OS than patients who had never
smoked (hazard ratio = 1.613, 95% confidence interval =
1.133 to 2.296; P = 0.007) (Figure 2A, Table 2). Cigarette-
smoking patients did not have significantly different PFS
from patients who had never smoked (P = 0.222) (Figure 2B,
Table 2). In this regard, only 20.8% of patients who had
never smoked died as a result of colorectal cancer five years
Figure 2 Relationship between smoking and clinical outcomes of colorectal cancer patients. A, Kaplan-Meier survival curve demonstrating
cigarette-smoking was related to shorter overall survival; B, Kaplan-Meier survival curve demonstrating cigarette-smoking was not related to
progress-free survival.
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smoked. In multivariable analysis, smoking status was a po-
tentially independent factor in OS (P = 0.026) after
adjusting for gender, tumor size, pathological type and
differentiation.
Discussion
The prevalence of excessive weight and obesity worldwide
has been increasing markedly over the past decades [20].
Although the prevalence of obesity remains low in many
Asian countries compared with Western countries, many
Asian countries are experiencing a dramatic rise in the inci-
dence of obesity [1]. Excessive weight and obesity are asso-
ciated with higher risk of many cancers, including
colorectal cancer; however, few studies have focused on the
association between obesity and outcomes of cancer pa-
tients. Moreover, in Asian populations, only two published
studies have examined the effect of obesity on prognosis in
patients with colorectal cancer [14,18].
The results of the limited number of studies regarding
the influence of BMI on the outcomes of patients with
colorectal cancer are often unclear, even if conducted in the
same population. For instance, in a study that comprised a
total of 509 Korean colorectal cancer patients, excessive
weight had a favorable influence on OS compared with the
results obtained for normal-weight participants (P = 0.001),
whereas there was no significant difference in PFS
(P = 0.735) [14]. Contrary to this finding, Moon et al.
reported that there was no association between BMI and
OS (P = 0.210), but the overweight group showed a border-
line decrease in disease-free survival compared with
normal-weight participants (P = 0.064) [18]. Thesediscrepancies may result from the difference of BMI cat-
egory between the two study populations, aside from the
disparity in sample sizes. In the first study, the participants
were divided into normal-weight and overweight groups
based on BMI of 23 kg/m2, which is the criterion set for
Asian populations. In the latter study, the participants were
divided based on a BMI of 25 kg/m2 according to WHO
criteria for excessive weight. In our study, we divided
525 Chinese participants based on BMI above or below
23 kg/m2 according to the WHO classification for Asian
populations. BMI had no influence on OS or PFS of pa-
tients who underwent surgery for colorectal cancer, which
is inconsistent with the two previous studies.
The influence of BMI on the prognosis of patients with
colorectal cancer is not clear, with the few studies that have
addressed this question showing somewhat disparate
findings. Dignam et al. observed that BMI greater than
35 kg/m2 at diagnosis was associated with an increased risk
for recurrence and death from colon cancer [21]. In the
study by Sinicrope et al., obesity was further categorized as
class 1 (BMI = 30 to 34.9 kg/m2) and class 2/3 (BMI
≥35 kg/m2) [16]. In the class 2/3 obesity group, patients
had worse PFS and OS rates compared with normal-weight
patients. Moreover, patients in this group showed a trend
toward worse PFS in multivariate analysis. One possible ex-
planation for the difference between Western studies and
ours relates to the inclusion of more obese participants in
Western cohorts. Nevertheless, the Irish study showed no
significant difference between obese and nonobese cohorts
regarding survival, which is consistent with our results.
In our study, we found that both past and current
smokers had higher rates of mortality (OS) than patients
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who had smoked had a 10% increase in the risk of death
after surgery compared with the nonsmoking cohort. In
contrast to our study, the US population-based Cancer
Prevention Study II found that men and women who
smoked cigarettes for 20 or more years experienced higher
colorectal cancer death rates, adjusted for multiple potential
confounders [22]. However, Colangelo et al. reported that
the association between cigarette smoking and colorectal
cancer mortality was stronger in the younger age group
(age <50 years) than in the older age group [23]. In this
study, we did not further stratify the patients by smoking
status, because it was recorded only at baseline.Conclusion
Our data fail to suggest any significant impact of obesity on
outcomes of colorectal cancer patients. These findings sup-
port the proposal that cigarette smoking may be partially
responsible for divergent colorectal cancer mortality. Be-
sides, there are some limitations that should be considered.
These analyses were based on a retrospective study design,
so the potential for selection bias and missing data, includ-
ing medical history and comorbidities, may have affected
data analysis. Furthermore, BMI is the sole marker of obes-
ity and nutritional status. Baseline information on an-
thropometric measures of body weight was not available.
To better understand the impact of obesity and smoking
on the outcome of colorectal cancer patients, more large-
scale prospective studies are necessary.
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